Marc-Olivier Lapointe, Maxime Caru, Daniel Curnier, Marie-Josée Raboisson, Grégor Andelfinger, Maja Krajinović, Caroline Laverdière, Daniel Sinnett and Delphine Périé-Curnier
Article (2022)
An external link is available for this item| Department: | Department of Mechanical Engineering |
|---|---|
| PolyPublie URL: | https://publications.polymtl.ca/70763/ |
| Journal Title: | Journal of Pediatric Hematology/Oncology (vol. 45, no. 2) |
| Publisher: | Lippincott Williams & Wilkins |
| DOI: | 10.1097/mph.0000000000002538 |
| Official URL: | https://doi.org/10.1097/mph.0000000000002538 |
| Date Deposited: | 22 Dec 2025 14:30 |
| Last Modified: | 22 Dec 2025 14:30 |
| Cite in APA 7: | Lapointe, M.-O., Caru, M., Curnier, D., Raboisson, M.-J., Andelfinger, G., Krajinović, M., Laverdière, C., Sinnett, D., & Périé-Curnier, D. (2022). Dexrazoxane Treatments Limits Subclinical Cardiac Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors Exposed to Doxorubicin Treatments. Journal of Pediatric Hematology/Oncology, 45(2), 70-77. https://doi.org/10.1097/mph.0000000000002538 |
|---|---|
Statistics
Dimensions
